To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension .

Viatris logo

Viatris

Status and phase

Completed
Phase 4

Conditions

Impotence
Hypertension

Treatments

Drug: Sildenafil Citrate

Study type

Interventional

Funder types

Industry

Identifiers

NCT00150358
A1481187

Details and patient eligibility

About

To assess changes with respect to Erectile Dysfunction in subjects treated with Viagra and antihypertensive therapy.

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subjects with arterial hypertension treated with one or more antihypertensive agents, the doses of which have been stable for at least 4 weeks prior to the baseline visit, with a documented clinical diagnosis of ED and a confirmation of this by a qualification of 21 or less on the SHI-M.

Exclusion criteria

Subjects with resting sitting systolic blood pressure >170 or <110mmHg or resting sitting diastolic blood pressure >90 or <50mmHg, with significant cardiovascular disease and retinitis pigmentosa, treatment with nitrates, alfablockers or CYP3A4 inhibitors.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

16

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems